Skip to Main Content

Paper Details

Germline polymorphisms in genes maintaining the replication fork predict the efficacy of oxaliplatin and irinotecan in patients with metastatic colorectal cancer.
Br J Cancer
1
2022
Author NameAffiliation
Joshua MillsteinNorris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California
  • 1 - 1

Datasets

Release 1.2